You’ve undoubtedly heard that Australians are living longer.
The most recent Intergenerational Report for instance, projected that the number of Australians aged 65 and over would more than double by 2055, compared with 2015.
The Productivity Commission report, An Ageing Australia: Preparing for the Future, has also projected that with continued small increases in longevity, by 2100, it’s estimated that there will be more people aged 100 or more years than babies born in that year. 
But the question still remains – is there opportunity for investors to profit from this trend?
Keeping an older generation fit and healthy requires significant investment in certain areas such as healthcare and technology. Having some exposure in your portfolio to stocks tapped into this sector and their healthcare counterparts, may therefore make sense.
Investing in the healthcare sector
This demographic is likely to have implications and opportunities for investment markets.
Australia’s ageing population will potentially provide tailwinds for decades to come, boosting the demand for drugs, surgeries, medical devices, private hospitals, medical centres and aged-care facilities, as well as services such as nursing, pathology and radiology.
The stark reality – as set out by Deloitte – is that Australia’s ageing population brings health issues that drive up care demand and costs. Incidence of ailments such as coronary heart disease (CHD), cerebrovascular disease (stroke), dementia (including Alzheimer’s disease) and lung cancer increase greatly with age. 
It is not just Australia though.
Globally, healthcare spending will grow at 4.1 per cent a year between 2017 and 2021. This indicates that healthcare spend may grow faster than the global economy, as the world population expands and medical treatments increase.
Investment options: the ageing population trend
Global healthcare indexes
One way to gain exposure to the healthcare industry is via exchange-traded funds (ETFs).
Several ETF issuers have created vehicles that track global healthcare indices, giving investors access to the world’s largest listed pharmaceutical companies, medical device makers and healthcare stocks.
Be aware, however, that when investing in global markets, you may wish to consider risks such as currency risk as the Australian Dollar appreciates/depreciates against the currency in which the investment is denominated.
Australian Securities Exchange (ASX)
Alternatively, you can choose from a wide variety of local stocks exposed to healthcare. The ASX hosts Australia’s globalhealthcare stocks including those developing medical devices for sleeping and hearing as well as plasma based therapies. You can also get access to private hospital operators in Australia, some of the biggest in the world.
Other major domestic stocks include private hospital and medical centre operators as well as pathology, medical diagnostics, and pharmacy networks.
In the “wellness” industry, there’s also listed companies selling vitamins, bioceuticals (natural products for certain conditions), health foods, nutritional supplements and probiotics.
Possible opportunities in medical research and aged-care
Biotech – medical research
Australian medical research continues to shape the health and wellbeing of our nation, and has also proven to deliver return on investment for the Australian economy. Investing in Australian biotechnology companies however, may present a level of risk and is generally a longer-term investment proposition. This is because the treatments must pass a number of stages of clinical trials in order to reach federal approval.
The aged-care industry is also one that should benefit from the ageing population and rising spending, and it is well-represented on the stock exchange. However, the stocks have suffered from recent negative publicity concerning care practices, culminating in the announcement in September 2018 of a Royal Commission into the sector.
The other part of the profound demographic trend of an ageing population is that with advances in modern medicine, many older Australians are living healthier lives. According to the Australian Institute of Health and Welfare (AIHW), in general, Australians are not only living longer, they are enjoying more years in good health.
Stocks tapped into super
Finally, with $2.7 trillion now held in the superannuation system, the ageing population will increase outflows from this asset pool, as there will be a flow of money funding these years in retirement – although whether every retiree is able to fund a lifestyle to match their expectations cannot be guaranteed.
The point is that the nation will see a growing number of older Australians, healthy enough to enjoy their retirement and who may be prepared or are able to spend money enjoying life.
As a result, this may provide opportunities for a number of stocks tapped into the sector – less obviously than their healthcare counterparts.
Bottom line: for investors, having some exposure in your portfolio to the healthcare sector and its counterparts, may make sense given our increasing ageing population.
There are a many ways you can get involved in investing – whether it be in or outside your super.
 Treasurer of the Commonwealth of Australia - 2015 Intergenerational Report Australia in 2055 p. 1
 Productivity Commission report November 2013 - An Ageing Australia: Preparing for the Future p. 6 https://www.pc.gov.au/research/completed/ageing-australia/ageing-australia.pdf
 Australian Institute of Health and Welfare 2014. Ageing and the health system: challenges, opportunities and adaptations p 1-7: https://www.aihw.gov.au/getmedia/19dbc591-b1ef-4485-80ce-029ff66d6930/6_9-health-ageing.pdf.aspx
 Deloitte - 2015 Global health care outlook Common goals, competing priorities p. 1-4 https://www2.deloitte.com/gu/en/pages/life-sciences-and-healthcare/articles/2015-health-care-outlook.html
 Deloitte - 2018 Global health care outlook: The evolution of smart health care p. 5 https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-hc-outlook-2018.pdf
 KPMG, Economic Impact of Medical Research in Australia, released 16 October 2018 p 3-4 https://aamri.org.au/wp-content/uploads/2018/10/Economic-Impact-of-Medical-Research-exec-summary.pdf
 Australian Institute of Health and Welfare - Health-adjusted life expectancy in Australia: expected years lived in full health 2011 p. V-VI https://www.aihw.gov.au/reports/burden-of-disease/health-adjusted-life-expectancy-australia/contents/table-of-contents
 Current as at end of June quarter 2018 - The Association of Superannuation Funds of Australia: https://www.superannuation.asn.au/resources/superannuation-statistics
The article was prepared by BT Financial Group, a division of Westpac Banking Corporation ABN 33 007 457 14, and is current as at 17 December 2018.
This information does not take into account your personal objectives, financial situation or needs and so you should consider its appropriateness, having regard to these factors before acting on it. This information provides an overview or summary only and it should not be considered a comprehensive statement on any matter or relied upon as such. This information may contain material provided by third parties derived from sources believed to be accurate at its issue date. While such material is published with necessary permission, no company in the Westpac Group accepts any responsibility for the accuracy or completeness of, or endorses any such material. Except where contrary to law, we intend by this notice to exclude liability for this material.